General Information


DRACP ID  DRACP06002

Peptide Name  

Sequence  KALKALKKALKALKDGR

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Lipopeptides



Activity Information


Hemolytic Activity  Low hemolysis

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  C8H15O

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C84H158N26O20

Absent amino acids  CEFHIMNPQSTVWY

Common amino acids  K

Mass  213794

Pl  11.46

Basic residues  7

Acidic residues  1

Hydrophobic residues  8

Net charge  6

Boman Index  -2908

Hydrophobicity  -55.29

Aliphatic Index  115.29

Half Life 
  Mammalian: 1.4 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN114805493A

Patent Title  Preparation and anti-tumor effect of RGD/KLA integrated lipopeptide

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.